复方丹参滴丸治疗冠心病心绞痛的临床疗效观察
Clinical Effect Observation of Compound Danshen Dropping Pills in Treating Angina Pectoris of Coronary Heart Disease
摘要: 目的:探索复方丹参滴丸治疗冠心病心绞痛的临床疗效。方法:选取我院在2018年9月~2019年3月期间收治100例冠心病心绞痛患者随机分为研究组(50例)与对照组(50例)。对照组患者给予单硝酸异山梨酯缓释片进行治疗,研究组采用复方丹参滴丸治疗,分析两组的疗效。结果:研究组的治疗总有效率可达94.0%,显著高于对照组的78.0%,组间比较差异显著(χ2 = 5.12, P < 0.05);患者的心绞痛发作频率与发作时间均改善,且研究组的改善情况显著好于对照组;研究组中的不良反应发生率显著低于对照组。结论:在冠心病心绞痛的治疗中使用复方丹参滴丸,能够改善心绞痛的发作频率和发作时间,提高临床疗效,减少不良反应的发生,可供临床推广使用。
Abstract: Objective: To explore the clinical effect of Compound Danshen Dropping Pills on angina pectoris of coronary heart disease. Methods: 100 patients with coronary heart disease and angina pectoris admitted to our hospital from September 2018 to March 2019 were randomly divided into study group (50 cases) and control group (50 cases). Patients in the control group were treated with isosorbide mononitrate sustained-release tablets, while patients in the study group were treated with compound Danshen dripping pills, and the curative effects of the two groups were analyzed. Results: The total effective rate of the study group was 94.0%, significantly higher than 78.0% of the control group, with significant difference between the groups (χ2 = 5.12, P < 0.05). The frequency and duration of angina pectoris attacks were improved, and the improvement in the study group was significantly better than that in the control group. The incidence of adverse reactions in the study group was significantly lower than that in the control group. Conclusion: The use of compound Danshen dripping pills in the treatment of angina pectoris of coronary heart disease can improve the attack frequency and attack time of angina pectoris, improve the clinical curative effect and reduce the occurrence of adverse reactions, which can be widely used in clinical practice.
文章引用:黄帅, 白津宇, 高峰. 复方丹参滴丸治疗冠心病心绞痛的临床疗效观察[J]. 临床医学进展, 2019, 9(7): 815-820. https://doi.org/10.12677/ACM.2019.97125

参考文献

[1] 冉桦. 复方丹参滴丸在心血管方面的药理与临床研究[J]. 医药论坛, 2010, 2(10): 734-736.
[2] 许蓉. 盐酸曲美他嗪片与复方丹参滴丸对心血瘀阻型心绞痛发作频率及活动耐量的影响[J]. 时珍国医国药, 2011, 22(9): 2291-2292.
[3] 李庭凯, 王晓春, 照勤萍, 等. 复方丹参滴丸治疗冠心病心绞痛心血癖阻证临床研究[J]. 中西医结合心脑血管病杂志, 2014, 7(4): 215-216.
[4] 刘宇伟. 复方丹参滴丸治疗冠心病劳累性心绞痛80例疗效观察[J]. 中外医学研究, 2011, 9(6): 7-8.
[5] 李厚臣, 张爱国. 复方丹参滴丸治疗冠心病心绞痛1200例临床疗效观察[J]. 西南军医, 2013, 15(4): 444-445.
[6] 张俭, 张敏州, 王磊. 复方丹参滴丸治疗冠心病的系统评价[J]. 中国新药杂志, 2009, 18(6): 465-467.
[7] 陈焕清. 复方丹参滴丸对冠心病血管内皮功能的干预及其机制[J]. 中山大学学报, 2009, 30(4): 221-223.
[8] 幸志强, 曾旭初, 易春涛, 等. 丹参对冠心病患者血清脂质过氧化物及超氧化物歧化酶的响[J]. 中国中西医结合杂志, 1996, 16(14): 287-289.
[9] 王志军, 柯元南, 赵霞, 等. 复方丹参滴丸对高脂血证大鼠血小板功能的影响[J]. 北京中医药大学学报, 2008, 31(4): 254.
[10] 刘剑刚, 曹玉璋, 王晓芳. 复方丹参滴丸对血栓形成与凝血的影响[J]. 中国医学论坛报, 2003, 25(17): 161-163.
[11] 包铭. 复方丹参滴丸对冠心病患者血液流变学的影响[J]. 实用中西医结合杂志, 2005, 5(1): 12-14.
[12] 沙梅. 复方丹参滴丸治疗冠心病心绞痛的疗效观察[J]. 中西医结合心血管病电子杂志, 2015, 3(24): 74-75.
[13] 刘萍, 李艳丽, 李萍. 复方丹参滴丸治疗冠心病心绞痛的临床疗效分析[J]. 中国中医药科技, 2012, 19(4): 359.
[14] 叶太生, 张莹雯, 胡汉昆. 复方丹参滴丸治疗冠心病心绞痛的有效性和安全性系统评价[J]. 医药导报, 2013, 32(1): 100-105.
[15] 肖瑜, 刘永军. 复方丹参滴丸治疗冠心病心绞痛的Meta分析[J]. 中国药物评价, 2013, 30(1): 32-36.
[16] 艾广凤. 复方丹参滴丸治疗冠心病心绞痛的有效性和安全性[J]. 临床研究, 2016, 24(2): 7.
[17] 李永平. 复方丹参滴丸治疗冠心病心绞痛患者的临床疗效分析[J]. 中国继续医学教育, 2014, 6(8): 174-175.
[18] 汤峰. 复方丹参滴丸治疗冠心病的临床分析[J]. 中外医疗, 2017, 36(12): 124-125.
[19] 张建华. 复方丹参滴丸治疗冠心病心绞痛疗效观察[J]. 中国药师, 2012, 15(9): 1328-1330.
[20] 梁卫东. 复方丹参滴丸治疗冠心病心绞痛的效果观察[J]. 北方药学, 2012, 9(8): 33-34.
[21] 李春霞, 张菊霞. 复方丹参滴丸治疗冠心病的系统评价研究[J]. 世界最新医学信息文摘, 2017, 17(18): 117.